|
IN THE NEWS:
The August issue of Extramural Nexus, a publication of the NIH Office of Extramural Research, is now available on-line. Among the dozen or so article are reports on the implementation of changes approved as part of the review of the peer review system and on an initiative to better track personnel involved in NIH funded research. That article reports that, "Over the next year the NIH plans to require postdocs to register in the eRA Commons..." The article also reports that "The NIH will modify the Senior/Key Personnel Report to include all personnel associated with the project for a month or more...and, coupled with the Commons accounts for postdocs, create a reliable linkage of postdocs to research projects."
http://nexus.od.nih.gov/nexus/nexus.aspx?Month=8&Year=2008&ID=0
Articles from The Scientist, Sept 2008
See “The future of US science policy” p. 30
Salary survey 2008 p. 45
Bio Business: Profile of AstraZeneca’s Karen Gotting-Smith p. 69
Careers: The scientist as politician p. 73
http://www.the-scientist.com/
Study of white medical students finds link between institutional demographics and perceptions of ability to care for diverse populations. (InsideHigherEd.com 9/9/08) http://www.insidehighered.com/news/2008/09/10/jama
Words From the Wise
Faculty mentorships have grown from informal chats between junior and senior colleagues to structured programs of professional development.(Chronicle of Higher Education, 9/12/08)
What Editors Want
A journal editor reveals the most common mistakes academics make when they submit manuscripts. (Chronicle of Higher Education, 9/12/08)
The Financial Times on Tuesday featured an article, "Big pharma gravitates to the academe." The article reports, "Colleges and universities have become the next generation research and development labs for drugmakers at a time when they are battling increased generic competition for top-selling medicines, and a dearth of drugs in the pipeline." A pharma executive who earlier was in academia is quoted, "In the past academics thought that pharma companies were too secretive, while pharma companies thought that academics lacked a firm understanding of the proprietary perspective and what it takes to move drugs from the laboratory into the clinic. Both sides have gotten over their hang-ups and have now realised that we need to break down the barriers...Pharma is realising it cannot do everything on its own...If big pharma stays siloed and the academic world stays siloed, that is a huge loss for human health."
http://www.ft.com/cms/s/0/841ff7e0-7872-11dd-acc3-0000779fd18c.html
America, a weekly newspaper sponsored by the Jesuits, featured a cover article by Uwe E. Reinhardt, the Princeton University health economist. Dr, Reinhardt discusses some of the "misleading clichés and false dichotomies that distort serious discussion of health care reform in this country." He focuses on some of the rhetoric popular in presidential campaigns: "private market versus government" health care or "private market versus socialized medicine." http://www.americamagazine.org/content/article.cfm?article_id=11011
http://tinyurl.com/63ye33 (related chart)
Business Week featured an article on "balance billing" and contended than in many cases "health-care providers are going after patients for money they don't owe." According to the article, balance billing typically "occurs when an insurance plan covers less than what a doctor, hospital, or lab service wants to be paid. The health-care provider demands the balance from the patient. Uncertain and fearing the calls of a debt collector, the patient pays up. Most consumers don't realize it, but this common practice, known as balance billing, often is illegal." http://tinyurl.com/6l7ztd
Why Do Faculty Leave? Reasons for Attrition of Women and Minority Faculty from a Medical School: Four-Year Results. Journal of Women's Health Sep 2008, Vol. 17, No. 7: 1111-1118. http://www.liebertonline.com/doi/pdfplus/10.1089/jwh.2007.0582 |